Pharma Stocks
-
Why the Alnylam Sell-Off Looks Overdone — and What Investors Are Missing
Alnylam Pharmaceuticals (ALNY +0.67%) looks like an investor’s nightmare at first glance. The drugmaker’s shares have lost more than half…
Read More » -
Why Eton Pharmaceuticals (ETON) Is Up 32.0% After Q2 Earnings Surge And Raised 2026 Outlook
Eton Pharmaceuticals reported past second-quarter 2026 results showing revenue of US$37.59 million versus US$18.93 million a year earlier, and net…
Read More » -
Marksans Pharma Limited (NSE:MARKSANS) Looks Like A Good Stock, And It’s Going Ex-Dividend Soon
Regular readers will know that we love our dividends at Simply Wall St, which is why it’s exciting to see…
Read More » -
Is Astellas Pharma’s First-Quarter 2026 Profit Surge Altering The Investment Case For Astellas Pharma (TSE:4503)?
Astellas Pharma Inc. reported past first-quarter 2026 results with sales of ¥640,914 million and net income of ¥141,828 million, alongside…
Read More » -
Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes
Eton Pharmaceuticals Inc. surged as pivotal positive clinical and regulatory news drove bullish sentiment; stocks have been trading up by…
Read More » -
NewAmsterdam Pharma (NAMS) Earnings Losses Raise The Question Of Whether The Stock Is A Bargain
NewAmsterdam Pharma earnings jolt investor focus NewAmsterdam Pharma (NasdaqGM:NAMS) moved into the spotlight after its latest earnings report showed second…
Read More » -
Ascendis Pharma (NasdaqGS:ASND) Stock Turns Profitable As YORVIPATH Drives Growth
Ascendis Pharma stock barely flinched after earnings, up less than 1% around €248 even though the headline numbers were anything…
Read More » -
Vertex Pharmaceuticals Just Hit an All-Time High. Here’s Why the Biotech Stock Could Soar Even More
The past couple of years have been volatile for Vertex Pharmaceuticals (VRTX -2.12%). Between clinical setbacks and worse-than-expected financial results,…
Read More » -
Why Sumitomo Pharma (TSE:4506) Is Up 6.1% After Strong Q1 Earnings And Cell Therapy Progress
Sumitomo Pharma Co., Ltd. reported first-quarter 2026 results with sales of ¥129,495 million and net income of ¥16,997 million, both…
Read More » -
ASX Penny Stocks To Watch In August 2026
The Australian market is experiencing some fluctuations, with the S&P/ASX 200 recently dipping by 0.23%, while Wall Street continues to…
Read More »